Ensign Peak Advisors’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,263
| Closed | -$59K | – | 2219 |
|
|
2022
Q1 | $59K | Sell |
5,263
-9,737
| -65% | -$109K | ﹤0.01% | 2106 |
|
|
2021
Q4 | $266K | Hold |
15,000
| – | – | ﹤0.01% | 1853 |
|
|
2021
Q3 | $345K | Hold |
15,000
| – | – | ﹤0.01% | 1692 |
|
|
2021
Q2 | $349K | Hold |
15,000
| – | – | ﹤0.01% | 1650 |
|
|
2021
Q1 | $467K | Hold |
15,000
| – | – | ﹤0.01% | 1602 |
|
|
2020
Q4 | $597K | Buy |
+15,000
| New | +$597K | ﹤0.01% | 1563 |
|